ImageneBio (IMA) Free Cash Flow (2020 - 2024)
Historic Free Cash Flow for ImageneBio (IMA) over the last 5 years, with Q4 2024 value amounting to -$28.2 million.
- ImageneBio's Free Cash Flow fell 2753.05% to -$28.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$46.0 million, marking a year-over-year increase of 4260.76%. This contributed to the annual value of -$46.0 million for FY2024, which is 4260.76% up from last year.
- Per ImageneBio's latest filing, its Free Cash Flow stood at -$28.2 million for Q4 2024, which was down 2753.05% from $13.0 million recorded in Q3 2024.
- Over the past 5 years, ImageneBio's Free Cash Flow peaked at $13.0 million during Q3 2024, and registered a low of -$28.2 million during Q4 2024.
- Moreover, its 5-year median value for Free Cash Flow was -$17.7 million (2022), whereas its average is -$15.1 million.
- As far as peak fluctuations go, ImageneBio's Free Cash Flow crashed by 13657.9% in 2021, and later surged by 16481.97% in 2024.
- Over the past 5 years, ImageneBio's Free Cash Flow (Quarter) stood at -$13.2 million in 2020, then dropped by 5.38% to -$13.9 million in 2021, then fell by 28.51% to -$17.9 million in 2022, then dropped by 23.45% to -$22.1 million in 2023, then dropped by 27.53% to -$28.2 million in 2024.
- Its Free Cash Flow stands at -$28.2 million for Q4 2024, versus $13.0 million for Q3 2024 and -$12.5 million for Q2 2024.